Clinical Trial Update: Soluble CD95 Ligand Role in the Pathophysiology of Non-infectious Active Uveitis

View source ↗

Summary

A completed clinical trial evaluated the role of soluble CD95 ligand in the pathophysiology of non-infectious active uveitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveitis

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Non-Infectious Active Uveitis | Status: COMPLETED